Modulation of anxiety behavior in the elevated plus maze using peptidic oxytocin and vasopressin receptor ligands in the rat

Examining the role of oxytocin in the interoceptive effects of 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’) using a drug discrimination paradigm in the rat

(2010) Jillian H. Broadbear et al.   ADDICTION BIOLOGY

Assessing the antidepressant-like effects of carbetocin, an oxytocin agonist, using a modification of the forced swimming test

(2010) Stella Chaviaras et al.   PSYCHOPHARMACOLOGY

Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats

(2009) D.A. Slattery et al.   NEUROPHARMACOLOGY

Oxytocin reduces anxiety via ERK1/2 activation: local effect within the rat hypothalamic paraventricular nucleus

(2008) Annegret Blume et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

The vasopressin system — From antidiuresis to psychopathology

(2008) Elisabeth Frank et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Brain Oxytocin: A Key Regulator of Emotional and Social Behaviours in Both Females and Males

(2008) I. D. Neumann   JOURNAL OF NEUROENDOCRINOLOGY

Dissociation of the anxiolytic-like effects of Avpr1a and Avpr1b receptor antagonists in the dorsal and ventral hippocampus

(2008) Elif Engin et al.   NEUROPEPTIDES

Characterization of the V1a antagonist, JNJ-17308616, in rodent models of anxiety-like behavior

(2008) C. J. Bleickardt et al.   PSYCHOPHARMACOLOGY